市場調査レポート

商品コード

マルチモーダルイメージングの世界市場の評価：技術別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Multimodal Imaging Market Assessment, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年10月25日
発行: Market Xcel - Markets and Data
ページ情報: 英文 238 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 661,455円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 837,843円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,205,318円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のマルチモーダルイメージングの市場規模は、2023年の45億2,000万米ドルから2031年に70億9,000万米ドルに達すると予測され、予測期間の2024年～2031年にCAGRで5.79%の成長が見込まれます。市場は、慢性疾患の増加、企業投資、精密診断に対する需要の高まり、政府の取り組みの増加、医用画像技術の進歩、マルチモーダルイメージングシステムの採用の増加などによって伸びており、今後も同じペースで成長すると予測されます。

マルチモーダルイメージングは、さまざまなイメージング技術を1つに統合したシステムであり、診断により詳細で正確な表示を提供します。複数のモダリティを1つに統合することで、従来のイメージング手法を強化し、複雑な生物学的構造やプロセスの詳細な可視化を可能にします。これにより、より正確な診断が可能となり、総合的に医用画像の質が向上します。

現代の医療において、マルチモーダルイメージングは、生物学的構造とその機能についての見識を提供することにより、重要な役割を果たしています。マルチモーダルイメージング市場の主な促進要因は、世界的な高齢化の進行による一般医療診断向けポイントオブケアイメージングソリューションに対する需要の増加や、医療システムのアップグレードに向けた政府の取り組み、支援的な償還政策による技術の可用性の向上などです。さらに、ポータブルマルチモーダルイメージング技術は継続的に向上しており、外来と救急サービスでの需要を促進し、コスト効率の高い新しい可動式システムの開発につながっています。例えば2023年1月、Cobalt Healthは、Siemens Healthineersの先進のPET/CT技術を使用したモバイルPET/CTサービスを導入しました。この可動式システムには、受付、待合室、検査室、4つの取り込み室、患者とスタッフに必要なその他の設備が完備されています。この製品の発売は、多様な環境における医療提供へのアクセスと利便性を向上させるために、可動式マルチモダリティイメージングソリューションへの需要が高まっていることを強く示していると言えます。

さらに、企業は先進の医療ソリューションへのアクセスを促進するため、世界各地で施設の拡張に投資しており、このことがマルチモーダルイメージング市場の成長を促進しています。例えば2024年3月、Wipro GE Healthcare Pvt.Ltd.は、現地製造と研究開発への96億米ドルの投資を発表しました。これにより、同社はインドでPET CT、CT、MRコイルの製造を現地化し、医療技術部門におけるインドの世界的な重要性を高める意向です。この投資は、国内と世界の医療ニーズの高まりに対応するため、現地生産能力を強化するもので、可動式マルチモーダルイメージングソリューションに対する需要の高まりを反映しています。

当レポートでは、世界のマルチモーダルイメージング市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

市場規模の分析と予測
- 金額
- 数量
市場シェアの分析と予測
- 技術別
- 用途別
- エンドユーザー別
- 地域別
- 市場シェア分析：企業別（金額）（上位5社とその他 - 2023年）
市場マップ分析（2023年）
- 技術別
- 用途別
- エンドユーザー別
- 地域別

第5章北米のマルチモーダルイメージング市場の見通し（2017年～2031年）

市場規模の分析と予測
- 金額
- 数量
市場シェアの分析と予測
- 技術別
- 用途別
- エンドユーザー別
- シェア：国別
各国の市場の評価
- 米国のマルチモーダルイメージング市場の見通し（2017年～2031年）
- カナダ
- メキシコ

第6章欧州のマルチモーダルイメージング市場の見通し（2017年～2031年）

ドイツ
フランス
イタリア
英国
ロシア
オランダ
スペイン
トルコ
ポーランド

第7章アジア太平洋のマルチモーダルイメージング市場の見通し（2017年～2031年）

インド
中国
日本
オーストラリア
ベトナム
韓国
インドネシア
フィリピン

第8章南米のマルチモーダルイメージング市場の見通し（2017年～2031年）

ブラジル
アルゼンチン

第9章中東・アフリカのマルチモーダルイメージング市場の見通し（2017年～2031年）

サウジアラビア
アラブ首長国連邦
南アフリカ

第10章バリューチェーン分析

第11章ポーターのファイブフォース分析

第12章 PESTLE分析

第13章価格分析

第14章市場力学

市場促進要因
市場の課題

第15章市場の動向と発展

第16章規制枠組みとイノベーション

規制当局の承認

第17章特許情勢

第18章ケーススタディ

第19章競合情勢

マーケットリーダー上位5社の競合マトリクス
上位5社のSWOT分析
主要企業上位10社の情勢
- Siemens Healthineers AG
- GE HealthCare
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Shanghai United Imaging Healthcare Co., LTD
- Neusoft Medical Systems Co., Ltd.
- MinFound Medical Systems Co., Ltd
- Spectrum Dynamics Medical
- Mediso Ltd.
- Bruker Corporation

第20章戦略的推奨

第21章当社について、免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 2. Global Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 3. Global Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 4. Global Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 5. Global Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 6. Global Multimodal Imaging Market Share (%), By Region, 2017-2031F
Figure 7. North America Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 8. North America Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 9. North America Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 10. North America Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 11. North America Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 12. North America Multimodal Imaging Market Share (%), By Country, 2017-2031F
Figure 13. United States Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 14. United States Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 15. United States Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 16. United States Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 17. United States Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 18. Canada Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 19. Canada Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 20. Canada Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 21. Canada Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 22. Canada Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 23. Mexico Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 24. Mexico Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 25. Mexico Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 26. Mexico Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 27. Mexico Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 28. Europe Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 29. Europe Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 30. Europe Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 31. Europe Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 32. Europe Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 33. Europe Multimodal Imaging Market Share (%), By Country, 2017-2031F
Figure 34. Germany Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 35. Germany Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 36. Germany Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 37. Germany Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 38. Germany Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 39. France Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 40. France Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 41. France Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 42. France Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 43. France Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 44. Italy Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 45. Italy Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 46. Italy Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 47. Italy Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 48. Italy Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 49. United Kingdom Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 50. United Kingdom Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 51. United Kingdom Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 52. United Kingdom Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 53. United Kingdom Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 54. Russia Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 55. Russia Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 56. Russia Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 57. Russia Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 58. Russia Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 59. Netherlands Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 60. Netherlands Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 61. Netherlands Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 62. Netherlands Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 63. Netherlands Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 64. Spain Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 65. Spain Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 66. Spain Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 67. Spain Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 68. Spain Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 69. Turkey Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 70. Turkey Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 71. Turkey Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 72. Turkey Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 73. Turkey Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 74. Poland Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 75. Poland Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 76. Poland Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 77. Poland Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 78. Poland Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 79. South America Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 80. South America Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 81. South America Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 82. South America Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 83. South America Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 84. South America Multimodal Imaging Market Share (%), By Country, 2017-2031F
Figure 85. Brazil Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 86. Brazil Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 87. Brazil Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 88. Brazil Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 89. Brazil Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 90. Argentina Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 91. Argentina Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 92. Argentina Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 93. Argentina Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 94. Argentina Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 95. Asia-Pacific Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 96. Asia-Pacific Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 97. Asia-Pacific Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 98. Asia-Pacific Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 99. Asia-Pacific Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 100. Asia-Pacific Multimodal Imaging Market Share (%), By Country, 2017-2031F
Figure 101. India Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 102. India Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 103. India Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 104. India Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 105. India Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 106. China Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 107. China Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 108. China Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 109. China Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 110. China Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 111. Japan Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 112. Japan Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 113. Japan Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 114. Japan Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 115. Japan Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 116. Australia Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 117. Australia Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 118. Australia Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 119. Australia Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 120. Australia Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 121. Vietnam Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 122. Vietnam Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 123. Vietnam Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 124. Vietnam Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 125. Vietnam Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 126. South Korea Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 127. South Korea Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 128. South Korea Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 129. South Korea Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 130. South Korea Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 131. Indonesia Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 132. Indonesia Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 133. Indonesia Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 134. Indonesia Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 135. Indonesia Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 136. Philippines Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 137. Philippines Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 138. Philippines Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 139. Philippines Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 140. Philippines Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 141. Middle East & Africa Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 142. Middle East & Africa Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 143. Middle East & Africa Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 144. Middle East & Africa Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 145. Middle East & Africa Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 146. Middle East & Africa Multimodal Imaging Market Share (%), By Country, 2017-2031F
Figure 147. Saudi Arabia Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 148. Saudi Arabia Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 149. Saudi Arabia Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 150. Saudi Arabia Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 151. Saudi Arabia Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 152. UAE Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 153. UAE Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 154. UAE Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 155. UAE Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 156. UAE Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 157. South Africa Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
Figure 158. South Africa Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
Figure 159. South Africa Multimodal Imaging Market Share (%), By Technology, 2017-2031F
Figure 160. South Africa Multimodal Imaging Market Share (%), By Application, 2017-2031F
Figure 161. South Africa Multimodal Imaging Market Share (%), By End-users, 2017-2031F
Figure 162. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 164. By End-users Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX12161

Global multimodal imaging market is projected to witness a CAGR of 5.79% during the forecast period 2024-2031, growing from USD 4.52 billion in 2023 to USD 7.09 billion in 2031. The market for multimodal imaging systems is rising due to increasing chronic diseases, corporate investments, rising demand for precision diagnosis, increasing government initiatives, technological advancements in medical imaging, and increased adoption of multimodal imaging systems, and it is expected that it will keep growing at the same pace.

Multimodal imaging is a system integrating various imaging techniques into one, hence providing a more detailed and accurate view for diagnosis. It enhances the traditional imaging methodology by combining multiple modalities into one, enabling the visualization of complex biological structures and processes in detail. This leads to more accurate diagnoses, generally improving the quality of medical imaging.

In modern healthcare, multimodal imaging plays a vital role by providing insights into biological structures and their functions. Some of the key factors driving the multimodal imaging market include increasing demand for point-of-care imaging solutions for general medical diagnosis due to an increasing aging population worldwide, and government initiatives toward upgrading healthcare systems and making technology more accessible with supportive reimbursement policies. Additionally, portable multimodal imaging technology is continuously improving, fueling its demand for ambulatory and emergency services and leading to the development of new, cost-effective mobile systems. For instance, in January 2023, Cobalt Health introduced a mobile PET/CT service using the advanced Siemens Healthineers PET/CT technology. This mobile is fully fitted with a reception area, waiting room, lab, four uptake rooms, and all other necessary facilities for both patients and staff, just like any full PET/CT department. Its launch can underline the growing demand for mobile and multimodality imaging solutions to enhance access and convenience for healthcare delivery across diverse settings.

Furthermore, companies are also investing in the expansion of their facilities across the globe to promote access to advanced healthcare solutions, thereby driving the growth of the multimodal imaging market. For instance, in March 2024, Wipro GE Healthcare Pvt. Ltd. presented a USD 9,600 million investment in local manufacturing and R&D. With this, the company intends to localize the manufacturing of PET CT, CT, and MR coils in India and increase the country's significance globally in the MedTech sector. This investment reflects the growing demand for mobile and multimodal imaging solutions on account of strengthening local production capabilities to meet ever-growing healthcare needs in the country and worldwide.

Rising Prevalence of Chronic Diseases

With the rising incidences of prostate cancer, Alzheimer's disease, and various neurological disorders, there is an increasing demand for advanced and reliable diagnostic imaging technologies along with effective treatments. As these diseases become more prevalent, there is a growing demand for advanced imaging solutions combining various modalities. Hybrid imaging technologies have the potential to play a significant role in disease diagnosis and treatment. These technologies combine various imaging techniques for more accurate and comprehensive insights necessary for dealing with these health issues. According to the World Health Organization (WHO), there were approximately 1.47 million cases of prostate cancer in 2022 worldwide, and the cases are projected to increase to 2.63 million by 2045. This increase demonstrates, most poignantly, the need for better diagnostic techniques to save more lives. Multimodal imaging integrates two or more imaging techniques into one, thereby overcoming the drawbacks of single-modality imaging with the complementary data it offers. This approach offers a more comprehensive view of the disease and its progression. This enables clinicians to establish a more precise tumor staging, which is essential for selecting appropriate treatments. Therefore, multimodal imaging has become an important tool in cancer management. So, if these health conditions continue to grow, the demand for multimodal imaging is expected to grow.

For instance, in June 2023, at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, GE HealthCare unveiled an updated PET/MR system with AIR Technologies. The new SIGNA PET/MR AIR system was highlighted to enhance diagnostic precision, accelerate treatment assessment, and make patients more comfortable. This technology could make giant leaps in the diagnosis and treatment of prostate cancer, probably revolutionizing future medical imaging and treatment approaches.

Technological Advancements in Medical Imaging Drives the Market Growth

Continuous technological advancements within the multimodal imaging system strongly drive the multimodal imaging market growth. Some of the major developments are higher resolution and sensitivity, which together increase the precision and detail of imaging. These technological improvements remarkably enhance diagnostic capabilities and treatment planning. In oncology, for example, such advanced imaging may allow for more accurate visualization of the tumor to thus help in proper localization and the delivery of therapy with precision. Such a level of detail not only helps diagnostic accuracy but also enhances treatment planning for improved patient outcomes. Companies are strategically working on the development of advanced imaging technologies. The integration of the latest developments has helped companies build functionality into their products by enhancing the ability to improve effectiveness.

For instance, in November 2023, The Biograph Vision.X PET/CT from Siemens Healthineers received FDA approval. This represents a significant advancement in multimodal imaging by Siemens Healthineers. Driven by its leading flight time of 178 picoseconds, it uses advanced Optiso Ultra Dynamic Range (UDR) detector technology with 3.2 mm x 3.2 mm high-resolution LSO crystal elements. Its AIDAN platform featuring FlowMotion AI eases operational efficiency to the next level and personalizes the acquisition process for individual patients with AI-driven precision. This improves image clarity significantly, with great help in detecting even the smallest lesions for diagnosis with great accuracy. As these technologies continue to evolve, they are allowing more comprehensive assessments and fostering greater adoption, thus accelerating the growth of the multimodal imaging market. The continuous advancement in medical imaging represents a dynamic and increasingly crucial area for modern diagnostics and therapies.

Dominance of Technology in the Multimodal Imaging Market

The technology segment has a major share in the global multimodal imaging market. Several factors influence market growth, including investment in multimodal imaging systems, the growing prevalence of chronic diseases, and the increasing demand for better turnaround times, high-resolution imaging, and greater precision. The new product launch, together with the widespread adoption of the technology, underscores the increasing demand for this technology in the market. With advances in technology, the development of even more advanced imaging systems continues to expand the capabilities for diagnosing and treating patients. The continued efforts to improve precision and effectiveness in imaging diagnostics demonstrate the market expansion.

For instance, in June 2024, Siemens Healthineers AG introduced the Biograph Trinion PET/CT scanner. The high-performance scanner is energy-efficient and cost-efficient. It offers a range of clinical capabilities at lower operational costs. Some of its features include scalable, air-cooled digital detectors with enhanced spatial resolution and ultra-fast time-of-flight performance that further enhances small lesion detectability and sensitivity. An integrated platform replaces separate systems to carry out seamless workflows for PET and CT, smoothing the process. Artificial Intelligence and intelligent user interfaces further enhance operational efficiency. Such launches and advancements underline the dominance of PET/CT and drive growth in the multimodal imaging market.

North America Accounts for the Largest Share of the Multimodal Imaging Market

North America is expected to lead the multimodal imaging market in North America, which is driven by high demand from the United States and Canada. Various factors, including a high prevalence of chronic diseases, an aging population, and a well-structured healthcare system with strong reimbursement policies, support this leadership. The advanced healthcare infrastructure in the region encourages the wide use of advanced imaging technologies. Additionally, key players and companies headquartered in North America also contribute to enhancing their imaging solutions. Initiatives taken by organizations like the US FDA towards creating awareness about health, along with frequent new product launches and approvals, are driving demand for multimodal imaging tools in the region. This blend of leading healthcare developments with active market participation represents the leading position of North America in the multimodal imaging market.

For instance, in July 2024, Positron Corporation, a molecular imaging company, introduced the NeuSight PET-CT 3D 64-slice scanner in the United States and North American markets, which is advanced yet economical. NeuSight is manufactured by Neusoft Medical Systems, but Positron Corporation will handle the sales of NeuSight in the region as per its agreement with Shenyang Intelligent Nuclear Medical Technology Co., a subsidiary of Neusoft Medical Systems. This advanced technology has attained milestones in cardiac PET imaging by delivering high-quality imaging and diagnostic accuracy while ensuring patient comfort and ease of operation. Such innovative, pioneering technologies being developed within the region contribute to North America's leading position in the multimodal imaging market.

Future Market Scenario (2024-2031F)

Portable multi-modality imaging systems are the future of imaging. For instance, in April 2024, CDL Nuclear Technologies launched the new Mobile Cardiac PET/CT Trailer. This mobile unit brings sophisticated cardiac PET/CT imaging capabilities directly onto the doorstep of medical facilities, greatly improving access to quality diagnostic services. These would be very helpful for those facilities that do not have advanced imaging on-site or have had very limited access to advanced technology. The Mobile Cardiac PET/CT Trailer presents a minimal financial and operational risk to any hospital trying to expand cardiovascular imaging services. A module that fits seamlessly into the existing healthcare infrastructure with full conformance to regulatory standards, this product also underlines the growing trend toward flexible, on-demand imaging services. These innovations will be the future of multimodal imaging, offering unparalleled access and speed in diagnosis.

Artificial intelligence will continue to transform multimodal imaging. AI-based algorithms are increasingly integrated into the systems to allow for a smoother workflow and increase diagnostic accuracy. For example, in May 2024, Blue Earth Diagnostics announced a data-sharing agreement with Siemens Healthineers to share anonymized clinical data from its Phase 3 LIGHTHOUSE trial with the Company's medical imaging arm. Siemens Healthineers will use all the gathered data to further refine its AI algorithms for imaging prostate cancer. A major point in using AI will be integrating the solutions of multimodal imaging, hence optimizing the process of analysis and preparing essential information for patient care, driving future growth in the market for multimodal imaging.

Key Players Landscape and Outlook

There has been a high level of activity in the market through mergers and collaborations to increase the market shares of the leading companies. Partnerships and acquisitions have been strategic in developing capabilities, product portfolios, and market reach. This allows key players to fully utilize combined expertise and resources to drive growth and innovation within the sector. New product launches, regulatory approvals, and collaboration with hospitals are key strategies that leaders have employed in recent years. These moves represent the dynamic nature of the market, where key players build up their positions and meet changing market needs.

In August 2024, Siemens Healthineers agreed to complete the acquisition of the Novartis molecular imaging business for USD 223 million to expand operations for PET radiopharmaceuticals into Europe. This acquisition includes the Advanced Accelerator Applications (AAA), diagnostic manufacturing, and distribution network. Novartis remains with the therapeutic business of AAA. With the said agreement, Siemens cements its position in the European market for PET.

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Multimodal Imaging Market Outlook, 2017-2031F

4.1. Market Size Analysis & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. Market Share Analysis & Forecast
- 4.2.1. By Technology
  - 4.2.1.1. PET/CT Systems
  - 4.2.1.2. SPECT/CT Systems
  - 4.2.1.3. PET/MR Systems
  - 4.2.1.4. OCT/FMT Systems
  - 4.2.1.5. Others
- 4.2.2. By Application
  - 4.2.2.1. Oncology
  - 4.2.2.2. Cardiology
  - 4.2.2.3. Brain and Neurology
  - 4.2.2.4. Ophthalmology
  - 4.2.2.5. Research
  - 4.2.2.6. Others
- 4.2.3. By End-user
  - 4.2.3.1. Hospitals
  - 4.2.3.2. Diagnostic Imaging Centers
  - 4.2.3.3. Academic and Research Institutes
  - 4.2.3.4. Others
- 4.2.4. By Region
  - 4.2.4.1. North America
  - 4.2.4.2. Europe
  - 4.2.4.3. Asia-Pacific
  - 4.2.4.4. South America
  - 4.2.4.5. Middle East and Africa
- 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
4.3. Market Map Analysis, 2023
- 4.3.1. By Technology
- 4.3.2. By Application
- 4.3.3. By End-user
- 4.3.4. By Region

5. North America Multimodal Imaging Market Outlook, 2017-2031F*

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
- 5.1.2. By Volume
5.2. Market Share Analysis & Forecast
- 5.2.1. By Technology
  - 5.2.1.1. PET/CT Systems
  - 5.2.1.2. SPECT/CT Systems
  - 5.2.1.3. PET/MR Systems
  - 5.2.1.4. OCT/FMT Systems
  - 5.2.1.5. Others
- 5.2.2. By Application
  - 5.2.2.1. Oncology
  - 5.2.2.2. Cardiology
  - 5.2.2.3. Brain and Neurology
  - 5.2.2.4. Ophthalmology
  - 5.2.2.5. Research
  - 5.2.2.6. Others
- 5.2.3. By End-user
  - 5.2.3.1. Hospitals
  - 5.2.3.2. Diagnostic Imaging Centers
  - 5.2.3.3. Academic and Research Institutes
  - 5.2.3.4. Others
- 5.2.4. By Country Share
  - 5.2.4.1. United States
  - 5.2.4.2. Canada
  - 5.2.4.3. Mexico
5.3. Country Market Assessment
- 5.3.1. United States Multimodal Imaging Market Outlook, 2017-2031F*
  - 5.3.1.1. Market Size Analysis & Forecast
    - 5.3.1.1.1. By Value
    - 5.3.1.1.2. By Volume
  - 5.3.1.2. Market Share Analysis & Forecast
    - 5.3.1.2.1. By Technology
      - 5.3.1.2.1.1. PET/CT Systems
      - 5.3.1.2.1.2. SPECT/CT Systems
      - 5.3.1.2.1.3. PET/MR Systems
      - 5.3.1.2.1.4. OCT/FMT Systems
      - 5.3.1.2.1.5. Others
    - 5.3.1.2.2. By Application
      - 5.3.1.2.2.1. Oncology
      - 5.3.1.2.2.2. Cardiology
      - 5.3.1.2.2.3. Brain and Neurology
      - 5.3.1.2.2.4. Ophthalmology
      - 5.3.1.2.2.5. Research
      - 5.3.1.2.2.6. Others
    - 5.3.1.2.3. By End-users
      - 5.3.1.2.3.1. Hospitals
      - 5.3.1.2.3.2. Diagnostic Imaging Centers
      - 5.3.1.2.3.3. Academic and Research Institutes
      - 5.3.1.2.3.4. Others
- 5.3.2. Canada
- 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Multimodal Imaging Market Outlook, 2017-2031F

6.1. Germany
6.2. France
6.3. Italy
6.4. United Kingdom
6.5. Russia
6.6. Netherlands
6.7. Spain
6.8. Turkey
6.9. Poland

7. Asia-Pacific Multimodal Imaging Market Outlook, 2017-2031F

7.1. India
7.2. China
7.3. Japan
7.4. Australia
7.5. Vietnam
7.6. South Korea
7.7. Indonesia
7.8. Philippines

8. South America Multimodal Imaging Market Outlook, 2017-2031F

8.1. Brazil
8.2. Argentina

9. Middle East and Africa Multimodal Imaging Market Outlook, 2017-2031F

9.1. Saudi Arabia
9.2. UAE
9.3. South Africa

10. Value Chain Analysis

11. Porter's Five Forces Analysis

12. PESTLE Analysis

13. Pricing Analysis

14. Market Dynamics

14.1. Market Drivers
14.2. Market Challenges

15. Market Trends and Developments

16. Regulatory Framework and Innovation

16.1. Regulatory Approvals

17. Patent Landscape

18. Case Studies

19. Competitive Landscape

19.1. Competition Matrix of Top 5 Market Leaders
19.2. SWOT Analysis for Top 5 Players
19.3. Key Players Landscape for Top 10 Market Players
- 19.3.1. Siemens Healthineers AG
  - 19.3.1.1. Company Details
  - 19.3.1.2. Key Management Personnel
  - 19.3.1.3. Products and Services
  - 19.3.1.4. Financials (As Reported)
  - 19.3.1.5. Key Market Focus and Geographical Presence
  - 19.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
- 19.3.2. GE HealthCare
- 19.3.3. Koninklijke Philips N.V.
- 19.3.4. Canon Medical Systems Corporation
- 19.3.5. Shanghai United Imaging Healthcare Co., LTD
- 19.3.6. Neusoft Medical Systems Co., Ltd.
- 19.3.7. MinFound Medical Systems Co., Ltd
- 19.3.8. Spectrum Dynamics Medical
- 19.3.9. Mediso Ltd.
- 19.3.10. Bruker Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

マルチモーダルイメージングの世界市場の評価：技術別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Multimodal Imaging Market Assessment, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のマルチモーダルイメージング市場の見通し（2017年～2031年）

第5章 北米のマルチモーダルイメージング市場の見通し（2017年～2031年）

第6章 欧州のマルチモーダルイメージング市場の見通し（2017年～2031年）

第7章 アジア太平洋のマルチモーダルイメージング市場の見通し（2017年～2031年）

第8章 南米のマルチモーダルイメージング市場の見通し（2017年～2031年）

第9章 中東・アフリカのマルチモーダルイメージング市場の見通し（2017年～2031年）

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析